Health Astellas-Pfizer’s combination therapy halves risk of death in bladder cancer patients October 19, 2025 gopalkumarthakur@gmail.com An estimated 74.7% of patients treated with the combination were event-free at two years, compared to 39.4% who received surgery only, the companies said Related posts: Science Quiz: On blood pressure Institutionalising compassionate, structured, professional elder care Do we need more palliative medicine specialists in India? Covid virus changes sperm in mice, may raise anxiety in offspring: study
